Key Takeaways

Dr. George Tidmarsh resigned Sunday while under investigation

Tidmarsh says he was targeted after questioning a new fast-track drug approval program

A separate lawsuit accuses Tidmarsh of 'revenge,' which he denies

TUESDAY, Nov. 4, 2025 (HealthDay News) — The head of the U.S. Food and Drug Administration’s (FDA) drug division has resigned while under internal investigation, saying he was pushed out after raising concerns about how the agency planned to fast-track some new drugs.

Dr. George Tidmarsh , who joined the FDA in July, stepped down Sunday, The New York Times reported.

His resignation came just days after he was placed on administrative leave while federal officials investigated accusations connected to a lawsuit involving a drug company and one of its invest

See Full Page